entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
390834,FEM1AP2,pseudogene,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,1.22881739412858,-0.497364649499471,2.06193560675618,-0.241212503372945,0.809390420681353,0.961473650102656,NA
390834,FEM1AP2,pseudogene,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,11.5429135713449,0.0534180715432389,0.540283897117292,0.0988703750532883,0.921241190910914,0.995797437304219,patient-derived GBM cell lines (PDGCLs)
390834,FEM1AP2,pseudogene,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,0.456334646593544,-2.3559433225277,3.17903844216366,-0.741086767395062,0.458640832383304,0.861276018567986,A549
390834,FEM1AP2,pseudogene,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,0,NA,NA,NA,NA,NA,A549
390834,FEM1AP2,pseudogene,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,0,NA,NA,NA,NA,NA,A549
390834,FEM1AP2,pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,0.881986981229738,0.0768302106062689,2.19292046950051,0.0350355663485455,0.972051380427858,1,sigmoid colon organoid
390834,FEM1AP2,pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,0.881986981229738,2.50423010984666,1.94175125507041,1.28967606087931,0.197163154719512,0.903114526176878,sigmoid colon organoid
